openPR Logo
Press release

Lung Cancer Liquid Biopsy Market to Record Ascending Growth by 2025

04-17-2018 11:00 PM CET | Health & Medicine

Press release from: Transparency Market Research

Lung Cancer Liquid Biopsy Market to Record Ascending Growth

Liquid biopsy is a non-invasive substitute to surgical biopsies for the detection of molecular biomarkers. Liquid biopsy forms an integral part of precision medicine and has enormous diagnostic and treatment implications for oncology that can bring radical changes in clinical practice. It enables physicians to detect the development of a disease or a tumor examining a simple blood sample. The circulation of cancer cells or traces of RNA or DNA of cancer cells in the blood help to understand the line of treatment which is most likely to work for a patient. Not only this, liquid biopsies help augment capabilities to understand metastatic disease development.

Liquid biopsy is performed to detect cancer at an early stage. It is also used to plan a line of treatment for cancer, to find the efficacy of a line of treatment, and also to detect if cancer has come back. Liquid biopsy enables doctors to examine multiple samples of blood over a period of time, which helps to understand the molecular changes taking place in a tumor.

One of the key drivers of Lung Cancer Liquid Biopsy Market is increasing incidence of lung cancer. Lung cancer accounts for maximum cancer deaths across the world. The major factors responsible for the increasing prevalence of lung cancer are smoking, passive smoking, air pollution, and abnormalities in genes.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35906

The competitive landscape of the lung cancer liquid biopsy market features the presence of some top-notch companies. However, the market is likely to witness the entry of new companies. Key market players are focused on strengthening their product offerings and geographic presence by means of mergers and acquisitions and strategic alliances.

Liquid biopsy is a test performed on the blood sample to diagnose the cancer cells extracted from a tumor. Liquid biopsy is used as a diagnostic test to detect early-stage cancer. It is also employed for treatment planning or to see how well the treatment is benefitting the patient. It can also be used to check recurrence of cancer. The test also helps doctors understand the pattern of molecular changes in a tumor, as it allows to take multiple samples of the blood over time.

The incidence of lung cancer has considerably increased over the years, primarily due to smoking. Lung cancer is the leading cause of deaths caused by cancer worldwide. The two major types of lung cancer are small cell lung cancer and non-small cell lung cancer. Visibility under microscope determines the type of lung cancer. Non-small cell lung cancer is more common than small cell lung cancer. According to the National Cancer Institute, lung cancer is the leading cause of death in the U.S. Lung cancer is the second most commonly diagnosed cancer and remains the leading cause of cancer deaths worldwide, with an estimated 1.8 million new cases in 2012. Currently, the 5-year overall survival rate for lung cancer is 17%–22%, although survival differs with the stage of diagnosis. Liquid biopsy holds a great potential in lung cancer diagnostics. However, liquid biopsy faces numerous challenges while being adopted in the clinical practices such as optimizing and standardizing sample gathering, implementing uniform analytical procedures, identifying the circulating analytes that are most likely to yield useful information, and performing sufficiently large-sized multi-center clinical trials required for validating specific analysis protocols.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=35906

Physicians are able to determine the treatment pattern for patients with the help of results obtained through liquid biopsy. These advantages are augmenting the focus of vendors on providing a personalized treatment plan to patients with lung cancer. Personalized medicine guarantees targeted and actionable medication. The application of liquid biopsy for personalized medicine is expected to be one of the key factors to have a positive impact on the lung cancer liquid biopsy market during the forecast period. However, lung cancer misdiagnosis, inadequate tumor sampling, and delayed diagnoses are also common due to limitations of the tissue biopsy.

Based on biomarker type, the global lung cancer liquid biopsy market can be divided into CTC (circulating tumor cells), ctDNA (circulating tumor DNA), and exosomes & RNA. In terms of application, the market can be segmented into small cell lung cancer and non-small cell lung cancer. Based on end-user, the global lung cancer liquid biopsy market can be classified into diagnostic & imaging centers, hospitals, academics & research centers, and others. Increase in the prevalence and incidence of lung cancer worldwide and rise in awareness about the disease are major factors fueling the global lung cancer liquid biopsy market. However, technological advancements in imaging such as computed tomography (CT) and magnetic resonance imaging (MRI) are likely to restrain the global lung cancer liquid biopsy market during the forecast period.

The global lung cancer liquid biopsy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is projected to register a high CAGR during the forecast period, due to large patient pool in the region. Growing awareness among patients as well as health care professionals has led to increase in the number of diagnosed cases of lung cancer in Asia, especially China and India. North America is projected to dominate the global lung cancer liquid biopsy market in the near future, due to factors such as rise in the number of reported lung cancer cases and significant investments in R&D of effective treatment alternatives in the region.

Key players operating in the global lung cancer liquid biopsy market are Biocept, Exosome Diagnostics, F. Hoffmann-La Roche, QIAGEN, Agena Bioscience, AccuraGen, BARD1, Bio-Rad Laboratories, Biodesix, Cancer Genetics, Circulogene, CellMax Life, CLEARBRIDGE BIOMEDICS, and Cynvenio Biosystems.

View Report -

https://www.transparencymarketresearch.com/lung-cancer-liquid-biopsy-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Liquid Biopsy Market to Record Ascending Growth by 2025 here

News-ID: 1020436 • Views: 294

More Releases from Transparency Market Research

Latest TMR Report Explores Impact of COVID-19 Outbreak on Industrial Air Compres …
Industrial Air Compressor Market: Introduction The global industrial air compressor market is anticipated to reach US$ 26.6 Bn by 2030. The industrial air compressor market is projected to expand at a CAGR of ~4% from 2020 to 2030 based on revenue. According to the report, Asia Pacific was a significant contributor to the industrial air compressor market in terms of revenue in 2019. The prominent market share of the region is
Automotive Head-up Display (HUD) Market is projected to surpass US$ 4.7 Bn by 20 …
Automotive Head-up Display (HUD) Market: Introduction According to the report, the global automotive head-up display (HUD) market is projected to surpass US$ 4.7 Bn by 2030, expanding at a CAGR of ~22% during the forecast period. Rise in demand for comfort and safety features in vehicles is likely to boost the automotive head-up display (HUD) market across the globe. Increase in preference for utility vehicles and luxury vehicles, in conjunction with
Understanding Impact of COVID-19 on Retail Clinics Market
Global Retail Clinics Market – Overview Retail clinics are the ones that provide primary healthcare services across departmental stores, supermarkets, and retail stores. These clinics have a registration desk, a waiting area, washroom, a couple of examination rooms, and a small desk for reception. These retail clinics are gaining immense popularity as they are highly beneficial for public health, easily accessible, and also help in reducing the pressure on public healthcare
Potential Impact of COVID-19 on Self-tanning Products Market
Self-tanning Products Market: Introduction Transparency Market Research delivers key insights on the global self-tanning products market. In terms of revenue, the global self-tanning products market is estimated to expand at a CAGR of ~6% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the global self-tanning products market report. Obtain Report Details @ https://www.transparencymarketresearch.com/self-tanning-products-market.html In terms of type, the self-tanning products market has been segmented

All 5 Releases


More Releases for Liquid

Liquid Biopsy Market
Liquid biopsies are non-invasive blood tests that detect tumor DNA & RNA fragments and circulating tumor cells (CTCs), which are released into the blood from the primary tumors and metastatic sites. It is a minimally invasive technology for the detection of molecular biomarkers, excluding expensive or invasive procedures. The global liquid biopsy market accounted for $634 million in 2016, and is estimated to reach
Liquid Applied Membranes Market 2025 |
Liquid Applied Membrane (LAM) is a lowly thickness waterproofing film that is employed in the form of a liquid covering to vertical along with horizontal surfaces. The LAM is, in addition, believed as a cutting-edge waterproofing chemical as well as its solid, consistent property, in addition to the ability to comply with each setup is making its need increase in the worldwide construction industry. Utilization of terrible value construction material
Liquid Milk Market
https://www.qandqmarketresearch.com/reports/7239773/liquid-milk-market-98 In 2017, the global Liquid Milk market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liquid Milk market based on company, product type, application and key regions. This report studies the global market size of Liquid Milk in key regions like North America, Europe, Asia
Liquid Productions announces name change
13 years since it’s foundation, top creative content production agency Liquid Productions is evolving, with a new name to match a new vision. As of the 10th October the new name for the business is LIQUONA. Repeatedly ranked by industry magazine Televisual as a Top 50 UK corporate production company, LIQUONA has grown from a bedroom startup video production company, to a full creative moving image agency. The name change reflects the development of
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Global Liquid Nitrogen Market 2017
Global Liquid Nitrogen Report 2017 Major Manufacture Analysis Of Liquid Nitrogen Market 2017. The report presents a Depth Research of the market growth factors and drivers. A Deep research of the Liquid Nitrogen Market limitations and the opportunities enable the user to make the future projection. The report also includes Company Profile, based on the manufacturing methods, technological advancements, and innovations. GET SAMPLE REPORT @ https://www.reportsmonitor.com/request-sample/?post=398982 The report has been prepared based